Summary
Clinical trials in rare diseases are complex and present unique challenges. However, patients in these trials are very vocal, with caretakers, family members, and advocates eager to share their experiences. By using actionable strategies to find, listen to, and learn from patients themselves, researchers can include their perspective in study design.
Register to download
The Patient Voice: Engaging Rare Disease Patients Improves Clinical Trial Enrollment & Retention
You may also be interested in:
resource
Opportunities in low-level radiocarbon microtracing: applications and new technology
14C-radiolabeled (radiocarbon) drug studies are central to defining the disposition of therapeutics in clinical development. Concerns over radiation,…
Case Study
Multi-stakeholder Collaboration Achieves Rapid Study Start-up for an Advanced Therapeutic
PRA worked with an emerging biotech firm to implement a first-in-human clinical trial using a live biotherapeutic product for a rare disease…
Poster
Real-World Misuse Abuse and Dependence of Abuse Deterrent
Abuse deterrent formulations of opioid medications (ADOs) may help curtail the widespread abuse, misuse, and diversion of these products.With the…